Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancerLEVITT, N. C; PROPPER, D. J; GANESAN, T. S et al.British journal of cancer. 2005, Vol 93, Num 1, pp 60-69, issn 0007-0920, 10 p.Article

Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazinePROPPER, D. J; BRAYBROOKE, J. P; LEVITT, N. C et al.British journal of cancer. 2000, Vol 82, Num 11, pp 1759-1763, issn 0007-0920Article

Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitorESKENS, F. A. L. M; LEVITT, N. C; SPARREBOOM, A et al.Clinical cancer research. 2000, Vol 6, Num 2, pp 431-433, issn 1078-0432Article

Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumoursPROPPER, D. J; BRAYBROOKE, J. P; HARRIS, A. L et al.Annals of oncology. 1999, Vol 10, Num 8, pp 923-927, issn 0923-7534Article

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancerKHAN, O. A; RANSON, M; MICHAEL, M et al.British journal of cancer. 2008, Vol 98, Num 10, pp 1614-1618, issn 0007-0920, 5 p.Article

Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancerPROPPER, D. J; LEVITT, N. C; HARRIS, A. L et al.British journal of cancer. 2000, Vol 82, Num 11, pp 1776-1782, issn 0007-0920Article